Global IVF Market

1    Research Scope and Methodology
1.1    Scope of the Report
1.2    The Global IVF Market Research Methodology
1.2.1    Primary Data Sources
1.2.2    Secondary Data Sources

2    Introduction to IVF Market
2.1    Evolution and IVF Technology Advancement
2.2    IVF Market by End Users
2.2.1    Hospitals
2.2.2    Surgical Centre
2.2.3    Clinical Research Institutes
2.2.4    Fertility Clinics

3    Market Dynamics
3.1    Market Drivers
3.1.1    Infertility Increasing at a High Rate
3.1.2    Increasing Awareness and Willingness about Egg and Sperm Donation
3.1.3    Presence of Surrogacy Market
3.1.4    Advancement of Assisted Reproductive Technologies and Methods
3.1.5    Others
3.2    Market Challenges
3.2.1    High Cost of the Whole Tenure of the IVF Procedure
3.2.2    Ethical Issues and Social Justice
3.2.3    Lack of Awareness and Education in Developing Countries
3.2.4    Increasing Cases of Multiple Births and Pregnancies
3.3    Market Opportunities
3.3.1    Availability of “Direct to Consumer Tests”
3.3.2    Focus toward Pre-Implantation Genetic Diagnosis

4    Competitive Insights
4.1    Key Market Developments & Strategies
4.1.1    New Product Launch, Development and Expansion
4.1.2    Acquisitions, Partnerships, Mergers and Collaborations
4.1.3    Business Contracts, Patents, Approvals & Other Events
4.2    Industry Attractiveness Analysis

5    Industry Analysis
5.1    Patent Analysis
5.2    Regulatory Bodies & Associations
5.3    Value Chain Analysis

6    Global IVF Market, Analysis & Forecast
6.1    Assumptions & Limitations for Analysis and Forecast of the Global IVF Market
6.2    Global IVF Market by Procedures
6.2.1    Intracytoplasmic Sperm Injection (ICSI)
6.2.2    Frozen Embryo Replacement (FER)
6.2.3    ZIFT and GIFT
6.2.3.1    Zygote Intrafallopian Transfer (ZIFT)
6.2.3.2    Gamete Intrafallopian Transfer (GIFT)
6.2.4    Others
6.3    Global IVF Market by Instruments and Reagents & Media
6.3.1    Instruments
6.3.1.1    Incubators
6.3.1.2    Cryosystem
6.3.1.3    Imaging System
6.3.1.4    Ovum Aspiration Pump
6.3.1.5    Sperm Separation System
6.3.1.6    Micro Manipulator System
6.3.1.7    Other Accessories and Disposables
6.3.1.7.1    Semen Analysis Chamber
6.3.1.7.2    Plastic Ware
6.3.1.7.3    Oocyte Retrieval Needles
6.3.1.7.4    Miscellaneous Disposables
6.3.2    Reagents and Media
6.3.2.1    Cryopreservation Media
6.3.2.2    Semen Processing Media
6.3.2.3    Embryo Culture Media
6.3.2.4    Others
6.4    IVF Market by Geography
6.4.1    North America
6.4.1.1    Market Analysis by Country
6.4.1.2    Recent Key Developments
6.4.1.3    Key players
6.4.2    Europe
6.4.2.1    Market Analysis by Country
6.4.2.2    Key Developments
6.4.2.3    Key Players
6.4.3    APAC
6.4.3.1    Market Analysis by Country
6.4.3.2    Key Developments
6.4.3.3    Key Players
6.4.4    Rest of the World (RoW)
6.4.4.1    Market Analysis by Country/Region
6.4.4.2    Key Developments
6.4.4.3    Key Players

7    Key Company Profiles
7.1    Affymetrix, Inc.
7.1.1    Overview
7.1.2    Financials
7.1.2.1    Financial Summary
7.1.3    SWOT Analysis
7.2    CombiMatrix
7.2.1    Overview
7.2.2    Financials
7.2.2.1    Financial Summary
7.2.3    SWOT Analysis
7.3    Illumina Inc.
7.3.1    Overview
7.3.2    Financials
7.3.2.1    Financial Summary
7.3.3    SWOT Analysis
7.4    LabCorp Of America
7.4.1    Overview
7.4.2    Financials
7.4.2.1    Financial Summary
7.4.3    SWOT Analysis
7.5    Quest Diagnostics
7.5.1    Overview
7.5.2    Financials
7.5.2.1    Financial Summary
7.5.3    SWOT Analysis
7.6    Roche Holding
7.6.1    Overview
7.6.2    Financials
7.6.2.1    Financial Summary
7.6.3    SWOT Analysis
7.7    Thermo Fisher Scientific
7.7.1    Overview
7.7.2    Financials
7.7.2.1    Financial Summary
7.7.3    SWOT Analysis
7.8    OvaScience
7.8.1    Overview
7.8.2    Financials
7.8.2.1    Financial Summary
7.8.3    SWOT Analysis
7.9    VitroLife
7.9.1    Overview
7.9.2    Financials
7.9.2.1    Financial Summary
7.9.3    SWOT Analysis
7.10    Snapshot of Other Key Players
7.10.1    Abbott Laboratories
7.10.2    Genea Biomedx
7.10.3    Irvine Scientific
7.10.4    Qiagen, Inc.
7.10.5    GE Healthcare
7.10.6    BioMérieux SA
7.10.7    Cepheid Inc.
7.10.8    List of Other Prominent Players

List of Tables
Table 1     Statistical Snapshot: Global IVF Market, by Procedure, 2015-2022
Table 2     Statistical Snapshot: Global IVF Market, by Geography, 2015-2022
Table 4.1     New Product Launch, Development and Expansion
Table 4.2     Recent Acquisitions, Partnerships, Mergers and Collaborations
Table 4.3     Recent Business Contracts, Patents, Approvals & Other Events
Table 4.4     Key Factors Considered for Threat of New Entrants
Table 4.5     Key Factors Affecting Bargaining Power of Buyers
Table 4.6     Key Factors Affecting the Bargaining Power of Suppliers
Table 4.7     Key Factors Affecting the Threat of Substitute
Table 4.8     Key Factors Determining Intensity of Competitive Rivalry
Table 5.1     Examples of Some Recent Patents
Table 5.2     Example of Some Regulatory Bodies/Associations/Consortium
Table 6.1     Recent Key Developments in North America
Table 6.2     Recent Key Developments in Europe
Table 6.3     Recent Key Developments in APAC
Table 6.4     Recent Key Developments in ROW
Table 6.9     List of Other Prominent Players

List of Figures
Figure 1     Pregnancy and Live Birth Rates, Through ART Cycles, by Women Age, 2012
Figure 2     Global IVF Market, by Procedure, 2015 and 2022 ($Billion)
Figure 3     Global IVF Market, by Type, 2015 and 2022 ($Billion)
Figure 4     Global IVF Market, by Geography, 2015 and 2022 ($Billion)
Figure 1.1     Global IVF Market Scope
Figure 1.2     Bottom-Up Approach for IVF Market Estimation
Figure 2.1     The IVF Process
Figure 2.2     IVF Market: Key Elements Covered
Figure 2.3     History & Evolution of IVF
Figure 3.1     IVF Market: Market Dynamics
Figure 3.2     IVF Market: Key Market Drivers
Figure 3.3     IVF: Key Challenges
Figure 3.4     IVF: Key Opportunities
Figure 4.1     Recent Market Development Strategy Snapshot Analysis
Figure 4.2    Key Market Developments & Strategies
Figure 4.3     Porter’s Five Forces Analysis
Figure5.1    Value Chain Analysis
Figure 6.1     Treatments Used in IVF
Figure 6.2     Global IVF Market Value, by Procedure, 2015-2022 ($Million)
Figure 6.3     ICSI Procedures Used in IVF
Figure 6.4     Instruments Used in ICSI
Figure 6.5     Reagents Used in ICSI
Figure 6.6     Advantages& Disadvantages of ICSI
Figure 6.7     Global IVF Market, by ICSI Procedure, 2015-2022 ($Million)
Figure 6.8     Procedure, Instruments and Media Used in FER
Figure 6.9     Global IVF Market, by FER Procedure, 2015-2022 ($Million)
Figure 6.10     Procedures of ZIFT and GIFT
Figure 6.11     Advantages and Disadvantages of ZIFT and GIFT Procedure
Figure 6.12     Global IVF Market, by ZIFT & GIFT Procedure, 2015-2022 ($Million)
Figure 6.13     Global IVF Market, by Other Procedures, 2015-2022 ($Million)
Figure 6.14     Global IVF Market, by Instruments, 2015-2022 ($Million)
Figure 6.15     Different IVF Incubators
Figure 6.16     Benefits of Time Lapse Incubator
Figure 6.17     Other Types of Incubator
Figure 6.18     Global IVF Market, by Incubator, 2015-2022 ($Million)
Figure 6.19     Cryosystem Types
Figure 6.20     Global IVF Market, by Cryosystem, 2015-2022 ($Million)
Figure 6.21     Global IVF Market, by Imaging System, 2015-2022 ($Million)
Figure 6.22     Global IVF Market, by Ovum Aspiration Pump, 2015-2022 ($Million)
Figure 6.23     Global IVF Market, by Sperm Separation System, 2015-2022 ($Million)
Figure 6.24     Global IVF Market, by Micro Manipulator System, 2015-2022 ($Million)
Figure 6.25     Global IVF Market, by Other Instruments, 2015-2022 ($Million)
Figure 6.26     Sperm Counting Chambers
Figure 6.27     Global IVF Market, by Semen Analysis Chamber, 2015-2022 ($Million)
Figure 6.28     Global IVF Market, by Plastic Ware, 2015-2022 ($Million)
Figure 6.29     Global IVF Market, by Oocyte Retrieval Needles, 2015-2022 ($Million)
Figure 6.30     Global IVF Market, by Miscellaneous Disposables, 2015-2022 ($Million)
Figure 6.31     Global IVF Market, by Cryopreservation Media, 2015-2022 ($Million)
Figure 6.32     Global IVF Market, by Semen Processing Media, 2015-2022 ($Million)
Figure 6.33     Global IVF Market, by Embryo Culture Media, 2015-2022 ($Million)
Figure 6.34     Global IVF Market, by Other Reagents, 2015-2022 ($Million)
Figure 6.35     Global IVF Market: Geography Coverage
Figure 6.36     Factors Affecting IVF Market in North America
Figure 6.37     Global IVF Market, by Geography, 2015-2022 ($Million)
Figure 6.38     North America: IVF Market Recent Trends
Figure 6.39     North America: IVF Market, 2015-2022 ($Million)
Figure 6.40     North America: IVF Market, by Countries, 2015-2022 ($Million)
Figure 6.41     Key Players in North American IVF Market
Figure 6.42     IVF Market Recent Trends in Europe
Figure 6.43     Europe: IVF Market, 2015-2022 ($Million)
Figure 6.44     Europe: IVF Market, by Countries, 2015-2022 ($Million)
Figure 6.45     Key Players in European IVF Market
Figure 6.46     IVF Market Recent Trends in APAC
Figure 6.47     APAC: IVF Market, 2015-2022 ($Million)
Figure 6.48     APAC: IVF Market, by Countries, 2015-2022 ($Million)
Figure 6.49     Key Players in APAC IVF Market
Figure 6.50     IVF Market Recent Trends in ROW
Figure 6.51     ROW: IVF Market, 2015-2022 ($Million)
Figure 6.52     ROW: IVF Market, by Regions, 2015-2022 ($Million)
Figure 6.53     Key Players in ROW IVF Market
Figure 7.1     Affymetrix: Overall Financials, 2013-2015
Figure 7.2     Affymetrix: Net Revenue by Business Segment, 2013-2015
Figure 7.3      Affymetrix: Revenue across Different Geographies, 2013-2015
Figure 7.4     Affymetrix: SWOT Analysis
Figure 7.5     CombiMatrix: Overall Financials, 2013-2015
Figure 7.6     CombiMatrix: SWOT Analysis
Figure 7.7     Illumina: Overall Financials, 2013-2015
Figure 7.8     Illumina: Net Revenue by Business Segment, 2013-2015
Figure 7.9     Illumina: Revenue across Different Geographies, 2013-2015
Figure 7.10     Illumina: SWOT Analysis
Figure 7.11     LabCorp: Overall Financials, 2013-2015
Figure 7.12     LabCorp: Net Revenue by Business Segment, 2013-2015
Figure 7.13     LABCORP: SWOT Analysis
Figure 7.14     Quest Diagnostics: Overall Financials, 2013-2015
Figure 7.15     Quest Diagnostics: Net Revenue by Business Segments, 2013-2015
Figure 7.16     Quest Diagnostics: SWOT Analysis
Figure 7.17     Roche Holding: Overall Financials, 2013-2015
Figure 7.18     Roche Holding: Net Revenue by Business Segments, 2013-2015
Figure 7.19     Roche Holding: Revenue across Different Geographies, 2013-2015
Figure 7.20     Roche Holding: SWOT Analysis
Figure 7.21     Thermo Fisher Scientific: Overall Financials, ($Billion)
Figure 7.22     Thermo Fisher Scientific: Net Revenue by Business Segments, ($Billion)
Figure 7.23     Thermo Fisher Scientific: Net Revenue by Geography, ($Billion)
Figure 7.24     Thermo Fisher Scientific: SWOT Analysis
Figure 7.25     OvaScience: Overall Financials, ($Million)
Figure 7.26     OvaScience: SWOT Analysis
Figure 7.27     VitroLife: Overall Financials, ($Million)
Figure 7.28     VitroLife: Net Revenue by Business Segments, ($Thousand)
Figure 7.29     VitroLife: Net Revenue by Geography, ($Thousand)
Figure 7.30     VitroLife: SWOT Analysis